Both RRM2 and ADH1B showed excellent diagnostic performance across all cancer types tested except STAD and PAAD (Fig. 3, I–N and Supplemental Fig. S3, E–V), supporting the potential of this pair of genes as pan-cancer diagnostic biomarkers to distinguish between normal and tumor tissues. Here, ADH1B is linked to cancer.